Cc1ccc(N2C(=O)[C@H]3NN=C(C(=O)CN4C(=O)c5ccccc5C4=O)[C@H]3C2=O)c(C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?